Biogen

Biogen

Yahoo Finance • 9 hours ago

Biogen nabs approval of subcutaneous version of Leqembi for initiation dose

[Alzheimers Concept Horizontal] travellinglight/iStock via Getty Images * The US FDA has approved Biogen (BIIB [https://seekingalpha.com/symbol/BIIB]) and Eisai's (ESALF [https://seekingalpha.com/symbol/ESALF]) (ESAIY [https://seekingal... Full story

Yahoo Finance • 10 hours ago

FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease

LEQEMBI IQLIK is a first-of-its-kind anti-amyloid treatment worldwide, offering at-home dosing for initiation and maintenance (approved in the U.S.) U.S. launch of LEQEMBI IQLIK as an initiation dose planned for late August 2026 TOKYO... Full story

Yahoo Finance • 15 hours ago

Stocks Retreat on Chipmaker Weakness and US-Iran Standoff

The S&P 500 Index ($SPX) (SPY) today is down -0.33%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.16%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -1.12%.  September E-mini S&P futures (ESU26) are down -0.33%, and September... Full story

Yahoo Finance • 15 hours ago

Stock Market Today, July 13: SK Hynix Tumbles 15% in South Korea, Leading Semiconductor Drop at Midday

At midday, the Nasdaq Composite (NASDAQINDEX:^IXIC) slipped 1.06% to 26,002.95, and the S&P 500 (SNPINDEX:^GSPC) fell 0.49% to 7,538.37 as growth sectors faltered, while the Dow Jones Industrial Average (DJINDICES:^DJI) declined 0.26% to 5... Full story

Yahoo Finance • 15 hours ago

Stock Market Today, July 13: Energy Stocks Cushion Dow as Tech Slides on Geopolitical Tensions

As of 11:45 a.m. ET, the S&P 500 (SNPINDEX:^GSPC) fell 0.39% to 7,546.18, the Nasdaq Composite (NASDAQINDEX:^IXIC) slid 0.92% to 26,039.24 on tech weakness, and the Dow Jones Industrial Average (DJINDICES:^DJI) dipped 0.21% to 52,528.23, s... Full story

Yahoo Finance • 16 hours ago

Stocks making the biggest moves midday: Nio, Braiin, AppLovin, SpaceX, SK Hynix & more

Check out the companies making the biggest moves midday: Braiin — The AI platform stock surged 62% after the company launched its Aria, an AI agent designed for the real estate industry. "We believe this creates a scalable recurring softwa... Full story

Yahoo Finance • 16 hours ago

Stocks Fall on Weakness in Chipmakers and Renewed US-Iran Hostilities

The S&P 500 Index ($SPX) (SPY) today is down -0.31%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.16%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -1.51%.  September E-mini S&P futures (ESU26) are down -0.29%, and September E... Full story

Yahoo Finance • 18 hours ago

American Express, Biogen upgraded: Wall Street's top analyst calls

American Express, Biogen upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by... Full story

Yahoo Finance • 20 hours ago

Truist upgrades Biogen to Buy on Alzheimer’s, pipeline optimism ahead of key data

Investing.com -- Truist Securities upgraded Biogen to Buy from Hold and raised its price target to $235 from $190, citing growing confidence in the company's Alzheimer's and immunology pipeline ahead of several major clinical data readouts... Full story

Yahoo Finance • 20 hours ago

Here Are Monday’s Best Wall Street Analyst Research Calls: Atmos Energy, Best Buy, Biogen, Capital One, Costco, Disney, Papa John’s International, Shopify, and More

Quick Read SK hynix surged 13% on its Nasdaq debut, raising $26.5 billion in what stands as the largest U.S. equity sale by a foreign company ever. Circle Internet Group (CRCL) surged 15% on OCC bank approval as Capital One (COF) earned a... Full story

Yahoo Finance • yesterday

Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer’s?

Biogen will present detailed Phase 2 study data for its experimental Alzheimer’s drug diranersen at a conference in London. Continue Reading... Full story

Yahoo Finance • 4 days ago

1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off

1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately... Full story

Yahoo Finance • 5 days ago

2 Fast-Growing Pharmaceutical Stocks to Buy Now

Key Points Incyte has added to its pipeline through acquisitions. It anticipates four new approvals and launches through 2027. TG Therapeutics' shares are up more than 90% so far this year.10 stocks we like better than Incyte › Incyte(NA... Full story

Yahoo Finance • 6 days ago

Stock futures slide as doubts rise over U.S.-Iran ceasefire

[The New York Stock Exchange on the Wall street sign] Dmitry Vinogradov Stock index futures were lower before the opening bell on Wednesday as U.S. President Donald Trump said the fragile truce between the U.S. and Iran is over after rene... Full story

Yahoo Finance • 8 days ago

3 Healthcare ETFs to Own in a Choppy Stock Market

Healthcare stocks are attractive in a choppy market. These funds, focusing on the broader sector, drugmakers, and biotechs, are worth a look. Continue Reading... Full story

Yahoo Finance • 12 days ago

1 S&P 500 Stock with Promising Prospects and 2 We Question

1 S&P 500 Stock with Promising Prospects and 2 We Question The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn't mean every stock is worth owning. Some companies face significant challenges, whether it's... Full story

Yahoo Finance • 18 days ago

Lilly, J&J and AbbVie Hit New Highs

This article first appeared on GuruFocus. Healthcare stocks outperformed the broader market on Friday, with Eli Lilly (NYSE:LLY), Johnson & Johnson (NYSE:JNJ) and AbbVie (NYSE:ABBV) among the major names hitting fresh 52-week highs. The... Full story

Yahoo Finance • 18 days ago

Lilly, J&J, AbbVie hit new 52-week highs as healthcare outperforms

[Wall Street Stock Market] meshaphoto/E+ via Getty Images Healthcare was a notable outperformer on Wall Street on Friday as several top sector components of the S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]), including Eli Lilly... Full story

Yahoo Finance • 20 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB).  Such investors are advised to contact Danielle Peyton at newaction@pomla... Full story

Yahoo Finance • 22 days ago

Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight

DelveInsight Business Research LLP The cutaneous lupus erythematosus market is expected to witness steady growth over the coming years, driven by increasing disease awareness, improved diagnostic rates, and a growing focus on autoimmune a... Full story